Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Boswellia serrata resin extract

EU orphan designation number: EU/3/02/117
Active ingredient: Boswellia serrata resin extract
Indication: Treatment of peritumoral oedema derived from brain tumours
Sponsor: Pharmasan GmbH
Obere Hardtstraße 18, 79114 Freiburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/10/2002 Orphan designation EMEA/OD/006/02 (2002)4108 of 21/10/2002
28/11/2006 Removal of orphan designation from Community Register